Gregory Haber, MD
Gastroenterology · New York, NYNPI 1659423937
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Olympus America Inc. at 42.3% of the total. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 503 payments — averaging $293.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$63K
- Boston Scientific$38K
- Olympus Corporation Of The Americas$15K
- Micro-tech Endoscopy USA, Inc.$9K
- Fujifilm Healthcare Americas Corporation$5K
- Exact Sciences$3K
- plus $16K from 31 others
Across 30 payments — averaging $5950.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Fujifilm Healthcare Americas Corporation$176K
- Medtronic$3K
What the payments were for
- Consulting fees$73,87650%
- Speaking & faculty fees$40,66928%
- Travel & lodging$12,2168%
- Food & beverage$20,54614%
- Gifts$4000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 107 | $62,548 |
| Boston Scientific | 127 | $37,965 |
| Olympus Corporation Of The Americas | 24 | $14,765 |
| Micro-tech Endoscopy USA, Inc. | 20 | $8,816 |
| Fujifilm Healthcare Americas Corporation | 11 | $4,633 |
| Exact Sciences | 2 | $2,774 |
| Creo Medical Inc. | 6 | $2,444 |
| Medtronic | 20 | $1,798 |
| Olympus Corporation | 3 | $1,645 |
| Braintree Laboratories, Inc. | 3 | $1,534 |
| Lumendi LLC | 3 | $1,504 |
| AbbVie | 51 | $1,090 |
| Applied Medical Resources Corporation | 1 | $1,000 |
| US Endoscopy | 1 | $1,000 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 63 | $851 |
| Covidien LP | 11 | $714 |
| Pentax Of America, Inc. | 5 | $472 |
| Intra-sana Laboratories | 2 | $417 |
| Endogastric Solutions, Inc | 2 | $228 |
| Conmed Corporation | 5 | $194 |
| Steris Corporation | 1 | $144 |
| Cook Medical LLC | 2 | $140 |
| ERBE USA Inc | 1 | $138 |
| Merck | 7 | $130 |
| Ambu Inc. | 1 | $124 |
| Bristol Myers Squibb | 4 | $122 |
| Apollo Endosurgery US Inc | 2 | $118 |
| Lucid Diagnostics Inc. | 1 | $59 |
| QOL Medical, LLC | 5 | $57 |
| Tersera Therapeutics LLC | 2 | $53 |
| Johnson & Johnson | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| 3-d Matrix, Inc. | 1 | $39 |
| Amgen | 1 | $31 |
| Redhill Biopharma Inc. | 2 | $28 |
| Vivus LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVIS EXERA III COLONOVIDEOSCOPE$18,556
- GENERAL - THERAPIES$14,451
- Olympus Biliary Devices$10,616
- VISIGLIDE$9,643
- DISPOSABLE TRIPLE LUMEN SPHINCTEROTOME$6,452
- GASTROINTESTINAL VIDEOSCOPE$6,150
- EVIS X1 VIDEO SYSTEM CENTER$5,951
- CLINICAL TRIAL PRODUCT$4,800
- FUJIFILM$4,134
- Single Use Repositionable Clip$3,831
- EndoClot PHS$3,817
- SINGLE USE GRASPING FORCEPS$3,685
- HANAROSTENT Biliary (NNN)$3,244
- Cologuard Collection Kit$2,700
- SPYGLASS$2,405
- Creo Medical$2,382
- EXALT Model D$2,259
- DiLumen$1,504
- SUTAB$1,500
- AXIOS$1,315
How this compares
$147,707 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.